Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
about
Roles of Copper-Binding Proteins in Breast Cancer.WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistanceDrug screening of cancer cell lines and human primary tumors using droplet microfluidics.International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.
P2860
Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ammonium tetrathiomolybdate tr ...... of breast cancer to cisplatin
@en
Ammonium tetrathiomolybdate tr ...... of breast cancer to cisplatin.
@nl
type
label
Ammonium tetrathiomolybdate tr ...... of breast cancer to cisplatin
@en
Ammonium tetrathiomolybdate tr ...... of breast cancer to cisplatin.
@nl
prefLabel
Ammonium tetrathiomolybdate tr ...... of breast cancer to cisplatin
@en
Ammonium tetrathiomolybdate tr ...... of breast cancer to cisplatin.
@nl
P2093
P2860
P356
P1433
P1476
Ammonium tetrathiomolybdate tr ...... of breast cancer to cisplatin
@en
P2093
Ada Hang-Heng Wong
Chu-Xia Deng
Cristine L Chisholm
Haitao Wang
Weiping Chen
Xiaoling Xu
P2860
P304
84439-84452
P356
10.18632/ONCOTARGET.12992
P407
P577
2016-12-01T00:00:00Z